Search Results - "Ntsekhe, Mpiko"

Investigating the antifibrotic potential of N‐acetyl seryl‐aspartyl‐lysyl‐proline sequence peptides.

Authors: Ramasamy, Vinasha Ntsekhe, Mpiko Sturrock, Edward

Source: Clinical & Experimental Pharmacology & Physiology. Nov2021, Vol. 48 Issue 11, p1558-1565.

Concurrent tuberculous pericarditis and lung adenocarcinoma presenting with cardiac tamponade.

Authors: Naicker, Kishendree Dalvie, Sameera Said-Hartley, Qonita et al.

Source: South African Journal of Oncology. 2023, Vol. 7, p1-5. 5p.

Quantification of echodensities in tuberculous pericardial effusion using fractal geometry: a proof of concept study.

Authors: Ntsekhe, Mpiko Mayosi, Bongani M. Gumbo, Tawanda

Source: Cardiovascular Ultrasound. 2012, Vol. 10 Issue 1, p30-35. 6p. 1 Black and White Photograph, 2 Charts, 1 Graph.

GeneXpert MTB/RIF Ultra vs Unstimulated Interferon γ (IRISA-TB) for the Diagnosis of Tuberculous Pericarditis in a Tuberculosis-Endemic Setting.

Authors: Randall, Philippa Esmail, Aliasgar Wilson, Lindsay et al.

Source: Open Forum Infectious Diseases. Mar2024, Vol. 11 Issue 3, p1-8. 8p.

Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases.

Authors: Salie, M. Taariq Yang, Jing Ramírez Medina, Carlos R. et al.

Source: Clinical Proteomics. 3/22/2022, Vol. 19 Issue 1, p1-12. 12p.

Geographic differences in patients with acute myocardial infarction in the PARADISE‐MI trial.

Authors: Butt, Jawad H. Claggett, Brian L. Miao, Zi M. et al.

Source: European Journal of Heart Failure. Aug2023, Vol. 25 Issue 8, p1228-1242. 15p. 4 Charts, 5 Graphs, 2 Maps.

Are Recommendations That Favor Other Agents Over Angiotensin-Converting Enzyme Inhibitors in Africans With Hypertension Justified?

Authors: Peter, Jonathan G. Ntusi, Ntobeko A.B. Ntsekhe, Mpiko

Source: Circulation. 3/12/2024, Vol. 149 Issue 11, p804-806. 3p.

Blood and Site of Disease Inflammatory Profiles Differ in Patients With Pericardial Tuberculosis and Human Immunodeficiency Virus Type 1.

Authors: Mutavhatsindi, Hygon Bruyn, Elsa Du Ruzive, Sheena et al.

Source: Open Forum Infectious Diseases. Mar2023, Vol. 10 Issue 3, p1-14. 14p.

HIV Infection Is Associated with a Lower Incidence of Constriction in Presumed Tuberculous Pericarditis: A Prospective Observational Study.

Authors: Ntsekhe, Mpiko Wiysonge, Charles S. Gumedze, Freedom et al.

Source: PLoS ONE. 2008, Vol. 3 Issue 6, p1-5. 5p. 1 Diagram, 2 Charts, 1 Graph.

Advancing global health through cardiovascular research, mentorship, and capacity building: in memoriam, professor Bongani Mayosi (1967–2018).

Authors: Nachega, Jean B. Ntsekhe, Mpiko Volmink, Jimmy et al.

Source: Pilot & Feasibility Studies. 10/3/2018, Vol. 4 Issue 1, pN.PAG-N.PAG. 1p.

Challenges of Cardiovascular Disease Risk Evaluation in People Living With HIV Infection.

Authors: Kengne, Andre Pascal Ntsekhe, Mpiko

Source: Circulation. 5/22/2018, Vol. 137 Issue 21, p2215-2217. 3p.

Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study.

Authors: Pandie, Shaheen Peter, Jonathan G. Kerbelker, Zita S. et al.

Source: BMC Medicine. 2014, Vol. 12 Issue 1, p1-22. 22p. 1 Diagram, 3 Charts, 2 Graphs.

Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry.

Authors: Mayosi, Bongani M Wiysonge, Charles Shey Ntsekhe, Mpiko et al.

Source: BMC Infectious Diseases. 2006, Vol. 6 Issue 1, p2-9. 9p. 6 Charts.

Prevalence, Hemodynamics, and Cytokine Profile of Effusive-Constrictive Pericarditis in Patients with Tuberculous Pericardial Effusion.

Authors: Ntsekhe, Mpiko Matthews, Kerryn Syed, Faisal F. et al.

Source: PLoS ONE. Oct2013, Vol. 8 Issue 10, p1-1. 1p.

Cardio-Thoracic Ratio Is Stable, Reproducible and Has Potential as a Screening Tool for HIV-1 Related Cardiac Disorders in Resource Poor Settings.

Authors: Esmail, Hanif Oni, Tolu Thienemann, Friedrich et al.

Source: PLoS ONE. 10/4/2016, Vol. 11 Issue 10, p1-10. 10p.

Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.

Authors: Davidson, Sean M. Lukhna, Kishal Gorog, Diana A. et al.

Source: Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy Oct2022; Vol. 36 (5).

Journal Info: Publisher: Springer Nature ISSN: 0920-3206

RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.

Authors: Davidson, Sean M. Lukhna, Kishal Gorog, Diana A. et al.

Source: Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy Jun2021.

Journal Info: Publisher: Springer Nature ISSN: 0920-3206

The diagnostic accuracy of pericardial and urinary lipoarabinomannan (LAM) assays in patients with suspected tuberculous pericarditis.

Authors: Pandie, Shaheen Peter, Jonathan G. Kerbelker, Zita S. et al.

Source: Scientific Reports. 9/16/2016, p32924. 1p.

A Compartmentalized Profibrotic Immune Response Characterizes Pericardial Tuberculosis, Irrespective of HIV-1 Infection.

Authors: Matthews, Kerryn Deffur, Armin Ntsekhe, Mpiko et al.

Source: American journal of respiratory and critical care medicine 12/15/2015; Vol. 192 (12).

Journal Info: Publisher: Oxford University Press / USA ISSN: 1073-449X

Achievements of primary prevention targets in individuals with high risk of cardiovascular disease: an 8-year follow-up of the Tromsø study.

Authors: Hagen AN Ariansen I Hanssen TA et al.

Source: European heart journal open [Eur Heart J Open] 2022 Sep 22; Vol. 2 (5), pp. oeac061. Date of Electronic Publication: 2022 Sep 22 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Published by Oxford University Press on behalf of the European Society of Cardiology Country of Publication: England NLM ID: 9918282081406676 Publication Model: eCollection Cited Medium: Internet ISSN: 2752-4191 (Electronic) Linking ISSN: 27524191 NLM ISO Abbreviation: Eur Heart J Open Subsets: PubMed not MEDLINE